Introduction
Malignant mesothelioma (MM) is an aggressive cancer with a dismal prognosis and limited therapeutic options and is usually associated with exposure to asbestos and other carcinogenic mineral fibers. 1 Because of this strong association with asbestos, in Western countries MM is most often diagnosed in the parietal pleura of older males professionally exposed to asbestos. 1 There are very few reports in the English literature about MM in China. [2] [3] [4] The incidence of MM in China has been estimated at 1.5 cases per million population, 5 which is much lower than in other countries. In addition to the English literature, we reviewed 68 papers representing all of the scientific manuscripts on MM in China that have been published in the Chinese literature (Supplementary Table 1 ). These papers reported a total of 1959 MM diagnoses, 293 of which were associated with asbestos exposure (approximately 15%), compared with more than 70% in most of the world. 1 This low incidence of asbestos-related MM was unexpected because the use of asbestos in China has not been restricted until recently. Amphibole asbestos was banned in 2002; however, the use of chrysotile asbestos continues, 3, 6 although it was banned in selected products and industries such as auto brakes (1999), household appliances (2005), shipbuilding (2007) , and mural material (2010). Asbestos mining and asbestos factories are still present in specific provinces and municipalities in China, such as in the province of Zhejiang in eastern China.
We recently discovered that in China MMs are surprisingly more frequent in young women (peritoneal localization), and we confirmed that many of these women were not exposed to asbestos. 7 These findings are puzzling and their reliability is largely linked to a correct diagnosis. Pathological diagnosis of MM is aided by immunohistochemistry (IHC) and it requires a correct interpretation of the results. We reviewed all the pleural and peritoneal malignancies that were diagnosed as MM during the years 2002-2015 in two medical centers in Zhejiang Province-one that sees predominantly non-asbestos-exposed patients and the other that sees predominantly asbestos-exposed patients (see later).
Materials and Methods

Specimen Collection
We collected the tissue slides used to diagnose 92 putative MMs in the Zhejiang Cancer Center Hospital (ZJCC), which is the largest university cancer hospital in the province of Zhejiang and located in the city of Hangzhou, and in the Yuyao People's Hospital (YPH), which is located 112 kilometers from Hangzhou in the town of Yuyao, where there is a florishing asbestos textile industry. There were a total of 92 diagnoses of MM: 34 in the pleura, 56 in the peritoneum, and two in the tunica vaginalis. Of the confirmed diagnoses of MM, 28 were from ZJCC and 24 were from YPH. Demographic and epidemiological information on this set of samples has been presented elsewhere. 7 This retrospective study was approved by the Zhejiang Cancer Hospital Ethical Committee and the Zhejiang Academy of Medical Sciences Ethical Committee.
Pathological Review
All initial diagnoses of MM were supported by some, at times limited, IHC. The histopathological review of these MMs-and of the available IHC results-was conducted jointly by pathologists from the ZJCC (Z. G.) and from the University of Hawaii Cancer Center (M. C.) with extensive experience in MM diagnosis. These specimens were obtained from tissue biopsies and fine-needle biopsies. A set of IHC analyses was ordered on the basis of histological appearance, sex, and location of the tumor (for example, ER and PR stains were ordered only for peritoneal malignancies in women), and final diagnoses were made concurrently by Z. G. and M. C.
IHC
When tissue was available, biopsy specimens were stained for calretinin, Wilms tumor 1 (WT1), D2-40, MOC31, BerEP4, CAM5.2, thyroid transcription factor-1 (TTF-1), napsin A, CD15, paired homeobox 8 (PAX8), and BRCA1 associated protein 1 (BAP1), and for ER and PR in peritoneal tumors. These immunostains help differentiate MM from other malignancies. [8] [9] [10] [11] [12] In addition, those cases in which the differential diagnosis included squamous cell carcinoma (SCC) were stained also for CK5/6, p63, and p40. As a control for these IHC stains, we stained 10 primary lung adenocarcinomas in parallel: 10 primary lung SCCs and 15 primary carcinosarcomas (lung [5] , esophagus [1] , mediastinum [1] , breast [1] , pancreas [2] , cervix [2] , liver [1] , stomach [1] , and duodenum [1] ). These cancer types were chosen because they often represent a diagnostic challenge in the differential diagnosis with MM. [8] [9] [10] [11] [12] IHC was performed with the antibodies listed in Supplementary 
Statistical Analyses
Comparisons among proportions were carried by using Fisher's exact test or the chi-square test. Sensitivity, specificity, and predictive values for each immunostain were calculated by comparing MM with all other non-MM malignancies. A p value less than 0.05 was deemed significant. All statistical analyses were carried with GraphPad Prism, version 7.00 (GraphPad Software, La Jolla, CA).
Results
Diagnostic Confirmation of MM Related to Tumor Location
There were a total of 92 MM diagnoses during the years 2002-2015 in our two reference centers, ZJCC and YPH. We confirmed the diagnosis of MM in 12 of 34 of the pleural tumors (35.3%) (10 in women and two in men), in 38 of 56 of the peritoneal tumors (67.9%) (32 in women and six in men), and in two of two of the tumors of the tunica vaginalis (100%) ( Table 1) . Diagnostic confirmation of MM was statistically more frequent for peritoneal tumors than for pleural tumors (Fisher's exact test, p < 0.01). No definitive conclusion could be drawn on tumors of the tunica vaginalis given their rarity overall and in our sample set. From these results, we can conclude that pleural rather than peritoneal MM is most often misdiagnosed.
Sensitivity and Specificity of IHC for Diagnosis of MM
For 28 of 52 of the cases diagnosed as MM and for 19 of the 40 tumors in which the diagnosis of MM was not confirmed, the paraffin blocks used to make the initial diagnosis were available to perform additional IHC studies. As expected, [8] [9] [10] [11] compared with non-MM tumors, MM cells were characterized by strong membranous staining for cytokeratin (CK) CAM5.2 (Fisher's exact test, p < 0.01) and nuclear staining for calretinin (Fisher's exact test, p < 0.0001) and WT1 (Fisher's exact test, p < 0.0001) ( Table 2 ). The results of staining for the epithelial markers CEA, TTF-1, MOC31, BerEP4, PAX8, ER, and PR were negative in MM (ER/PR stains were used only in peritoneal tumors) (Supplementary Table 3 ). Full results on sensitivity, specificity, and predictive values of each of the mesothelial IHC markers of MM are shown in Supplementary Table 4 .
On the basis of our results, the chance of finding, for example, a poorly differentiated carcinosarcoma positive for all three major positive markers of MM (CAM5.2, calretinin, and WT1) is predicted from our results to be approximately 1%, whereas approximately 70% of MMs are expected to have these IHC characteristics (Fisher's exact test, p < 0.0001, with the probability of positivity for each marker considered an independent event). From these results, we can conclude that the regular use of all three positive MM IHC markers, CAM5.2, calretinin, and WT1, would significantly improve the accuracy of MM diagnosis in China.
Identification of MM mimickers. The 40 malignancies (both of the pleura and peritoneum) in which we ruled out the initial diagnosis of MM are shown in Table 1 . These included metastatic carcinomas from various organs, including the lung (TTF-1-positive, Napsin Apositive, and MOC31 positive), ovary (BerEP4 positive, MOC31 positive, PAX8 positive, ER positive, and PR positive), and kidney (CD15 positive and PAX8 positive); primary fibrous tumors (CD34 positive); highgrade sarcomas (CK negative); renal carcinosarcoma (PAX8 positive); and one case of chronic pleuritis. We could not make a definitive diagnosis in six CK-positive cases, which we diagnosed as poorly differentiated carcinomas because of their undifferentiated histological appearance and lack of reactivity for any MM marker. For these six cases, the paraffin block was not available for additional IHC studies. In 18 additional cases (inadequate specimens, eight from the pleura and 10 from the peritoneum [see Table 1 ]), we could not confirm the diagnosis of MM because these were tiny needle biopsy specimens in which invasion by malignant cells could not be identified and/or IHC data were conflicting and no paraffin block was available to perform additional studies. Figures 1 and 2 and Supplementary Figure 1 show hematoxylin and eosin staining and IHC results representative of these 92 biopsy specimens. Figure 1 shows representative hematoxylin and eosin staining and immunostain results in a case in which we confirmed the diagnosis of pleural epithelial MM compared with a case that we rediagnosed as lung adenocarcinoma, Figure 2 shows a case that we confirmed as biphasic pleural MM compared with a case that we rediagnosed as renal carcinosarcoma metastatic to the pleura, and Supplementary  Figure 1 shows a case that we confirmed as sarcomatoid MM compared with a case that we rediagnosed as primary fibrous tumor of the pleura.
BAP1 and INO80 Staining
A total of 35 adenocarcinomas, SCCs, and primary carcinosarcomas stained positive for nuclear BAP1 ( Supplementary Fig. 2 and Table 3 ). Strong nuclear staining was detected in nearly 100% of the tumor cells in all these tumors (except for two adenocarcinomas in which some tumor nodules contained cells showing BAP1 nuclear staining and some areas contained tumor nodules that were BAP1 negative, possibly representing tumor subclones that had lost BAP1 expression).
Different results were obtained in parallel immunostains of MM biopsy specimens (Fig. 3) : of the 17 epithelial type MMs, two showed diffuse nuclear BAP1 positivity, one was focally positive, and 14 were negative. Of the three biphasic MMs, one was BAP1 positive, one negative, and one showed focal positivity in the spindle component only, indicating either polyclonality 16 or that in spite of the morphological appearance, the spindle component was benign/reactive and that this was an epithelial-type MM. 17, 18 The two sarcomatoid MMs were BAP1 positive. In summary, we found that lack of BAP1 nuclear staining was preferentially associated with MM (Fisher's exact test, p < 0.0001). Consistently, lack of nuclear staining appears to be rare in lung cancer. 12 In this series 35 of 35 lung cancers showed positive BAP1 nuclear staining.
We stained all these MM biopsies for INO80, a protein involved in DNA replication that requires BAP1 for stabilization and localization on the DNA. It has been suggested that BAP1 mutations result in loss of INO80 nuclear staining. 19 The concordance between BAP1 and INO80 staining in our sample set was statistically significant ( Fig. 3) (chi-square test, p < 0.0001).
Discussion
A growing number of MMs are expected in rapidly industrializing countries in which asbestos use is still allowed, such as China and India. 1 In these countries, information about the incidence and the prevalence of MM is minimal. We conducted an epidemiological study that revealed unique characteristics of MMs in Chinese patients. In eastern China, MMs were significantly more frequent in young individuals, in women, and with a peritoneal localization compared with the U.S., European, and Australian data. 7 The mean age of MM diagnosis in the cases presented here was 50.6 years, and the range was 21 to 71 years. The mean age of MM in women was 51.2 and the mean age in men was 47.8. The mean age of MM diagnosis among asbestos-exposed individuals was 55.2, and among non-asbestos-exposed individuals the mean age of diagnosis was 47.3. 7 These findings are usually associated with genetic predisposition to MM (such as carriers of germline BRCA1 associated protein 1 gene [BAP1] mutations) or are associated with exposure since birth (such as environmental exposure or growing up in families of asbestos workers). 20 The latter hypothesis was ruled out. 7 Instead, in the Western world, MM occurs predominantly in asbestos-exposed individuals at a mean age of 72 years, as there is a long latency of about 40 to 50 years from the time of exposure to development of MM. 21, 22 This long latency provides an opportunity to identify and develop biomarkers for early detection. 23, 24 An additional surprising finding was that among these Chinese patients with MMs, the female-to-male ratio was 4:1 and the peritoneal-to-pleural ratio was 3:1, which is exactly the opposite of what is observed in the Western world. 7, 21, 22 Except for asbestos exposure, the demographics among the patients from the two hospitals were very similar: two of 28 patients with MM from ZJCC (7.1%) had history of asbestos exposure versus 18 of 24 patients with MM from YPH (75%). 7 Thus, both hospitals' MM cases comprised mostly young women. Therefore, in eastern China MMs occur predominantly in a different age group and sex than in the United States, and there seems to be no clear association with asbestos exposure. These surprising findings require additional investigation. Ethnicity might be relevant in determining pathogenesis and the molecular characteristics of cancer. 25 Here we have reported that MM in China is often misdiagnosed-especially in its pleural localization, in which we did not confirm approximately two-thirds of the diagnoses. In addition, to confuse epidemiological and other research studies, cancer misdiagnoses are associated with inappropriate or delayed medical treatment. Moreover, misdiagnoses can lead to unnecessary therapy; for example, a case of chronic pleuritis (a benign condition) is described here.
Among the cancer types erroneously identified as pleural MM, the most frequent were poorly differentiated metastatic carcinomas from the lung, kidney, and other organs. Metastatic carcinoma of the ovary was the most frequent MM mimicker in the peritoneum. This information should help Chinese pathologists to select more appropriate IHC markers to increase the accuracy of the diagnosis.
We confirmed that the most sensitive and specific IHC biomarkers to diagnose MMs in Chinese patients are the same as observed in Western countries (i.e., calretinin and WT1). We found that D2-40 was not specific as a MM marker, as it stained not only 88% of MMs but also 80% of carcinosarcomas and lung SCC and 40% of lung adenocarcinomas. CK5/6 stained epithelial type MMs, but it also stained SCC, which in some of the cases we reviewed caused confusion and misdiagnoses. CK5/6 did not stain sarcomatoid MM. Thus, we recommend WT1 and calretinin as MM markers over CK5/6, which however remains a useful additional marker when used in the proper context. Instead, we suggest that CAM5.2 be included in the diagnostic panel because it almost always elicits a positive result, helps document tumor invasion, and helps eliminate outliers such as melanoma and lymphomas, which at times may cause a problem in the differential diagnosis (especially in tumors showing poorly differentiated single small cells among reactive inflammatory cells). Moreover, CAM5.2 is helpful to identify sarcomatoid and biphasic MM (the results of staining for CAM5.2 are almost always positive in both epithelial and spindle cells) and to rule out various types of sarcomas that can show a morphological pattern identical to that of MM but that are not stained by CAM5.2. The results of staining for the epithelial markers TTF-1, Napsin A, CD15, MOC31, PAX8, P63, P40, ER, and PR were consistently (100%) negative in MM; CEA and BerEP4 occasionally stained a small fraction of MM cells.
On the basis of these data, our experience, and statistical considerations, we would recommend (1) considering invasion of nearby tissues a prerequisite to diagnose MM, which alone would eliminate dubious diagnoses that were made in inadequate specimens (see the 18 cases listed in Table 1 ), and (2) using supporting IHC with a minimum panel comprising CAM5.2, calretinin, WT1 (except in women with peritoneal tumors), and two or more epithelial markers that need to be chosen on the basis of location (ER, PR, and PAX8 for peritoneal tumors) and histological features (TTF-1 and MOC31 for adenocarcinomas, p63 and p40 when the differential is with SCCs, and PAX8 when the differential includes kidney cancer), as it would significantly increase the correct identification of MM in China and elsewhere.
Additional recently proposed negative IHC stains for MM diagnoses include BAP1. BAP1 is a deubiquitinase and crucial tumor suppressor in MM, the nuclear expression of which is absent in approximately 65% of MMs. [13] [14] [15] Loss of the expression of INO80, which is a protein involved in DNA replication and a BAP1 target, may co-occur with BAP1 loss. 19 Our findings, together with those of recent reports, 26 suggest that nuclear BAP1 immunostaining helps differentiate NSCLCs from MM. 12 Our study has two main limitations: (1) as our analysis started by reviewing putative MM diagnoses by Chinese pathologists, we do not know the percentage of MMs that are misdiagnosed as other cancer types and (2) our analysis was limited to two hospitals in eastern China and the results may therefore not be representative of the whole of China. ZJCC is the largest cancer hospital in the city of Hangzhou (where most patients do not have evidence of asbestos exposure), and YPH is the most important hospital in a nearby area with abundant presence of textile industry that uses chrysotile asbestos. 7 These two hospitals should be at the forefront of MM diagnosis in China, yet the percent of misdiagnoses was high.
The main reason for inaccurate diagnosis of MM in China appeared to be the use of an incomplete set of immunostains and/or the incorrect interpretation of the stain results, as well as an overall tendency to make a definitive diagnosis even when the evidence was inadequate and a repeat biopsy would instead be 27 Thus, the issue of the accuracy of MM diagnosis is not limited to China.
In our study WT1 proved to be the most specific and reliable marker to identify pleural MM. However, because WT1 can stain ovarian tumors, calretinin is much more specific than WT1 to diagnose peritoneal MM.
As the role of genetics in MM is increasingly being reevaluated, 13, 14, 28 and considering the unique clinicoepidemiological characteristics of MMs in Chinese patients, future studies should address the possible contribution of known and unknown genetic variants to MM in the Chinese population. Genetic studies to investigate whether the same gene alterations found in U.S. and Western MMs [29] [30] [31] [32] [33] [34] are found in MMs in Chinese patients would be most informative and might provide clues to the prevalence of peritoneal MM in young Chinese women. Of note, China still uses primary monkey cells to produce polio vaccines. 35 These cells are often heavily contaminated with simian virus 40 (SV40), 35 a DNA tumor virus that has been linked to MM. [36] [37] [38] The process that inactivates polio vaccine does not inactivate SV40; thus, millions were infected with infectious SV40 until 1963 in the United States and until the late 1970s in the USSR. 35 The possible contribution of SV40 to MM in China should be investigated.
In conclusion, the accuracy of MM diagnosis should be improved in China. As the need for adequate MM diagnoses will grow in China in the next decades, it is important to identify and address current pitfalls experienced by local pathologists. IHC represents a powerful tool to help correctly diagnose MM. The suggested set of immunostains, if used routinely, would significantly improve the accuracy of diagnosis.
